Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,781.27 +4.49 0.16%
FTSE 100 6,699.82 +3.03 0.05%
DAX 8,358.63 +6.65 0.08%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,616.10 -53.60 -0.24%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Xetra
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Morphosys AG

+ Add to Watchlist

MOR:GR

34.495 EUR 0.015 0.04%

As of 03:52:11 ET on 05/24/2013.

Company Profile for Morphosys AG (MOR)

MorphoSys AG is a biotechnology company. The Company uses proprietary technology to develop human antibodies tailored to treat specific diseases. MorphoSys is developing medicines to treat cancer and inflammation.

Contact Information

Morphosys AG

Lena-Christ-Strasse 48
Martinsried, 82152
Germany
Phone: 49-89-89927-0
Fax: 49-89-89927-222

Key Executives for Morphosys AG (MOR)

Simon E MoroneyChairman-Mgmt Board/CEOJens HolsteinCFO/Member-Mgmt Board
Marlies SprollChief Scientific OfficerArndt SchotteliusChief Development Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil